Funded Projects › FP7
MULTIFUN · Multifunctional Nanotechnology for selective detection and Treatment of cancer
The aim of the MultiFun consortium is to develop and validate a novel and minimally-invasive nanotechnology system to improve cancer diagnosis and treatment. MultiFun nanotechnology is based on multifunctionalised magnetic nanoparticles to selectively target and eliminate breast and pancreatic cancer (stem) cells. The improved magnetic features of the MultiFun magnetic nanoparticles will lead to potential medical applications such as contrast agents and magnetic heating inductors. Moreover, magnetic nanoparticles can be functionalised with ligands to increase their affinity towards cancer cells in order to facilitate diagnosis of tumours by MRI. Targeting peptides and antibodies will be employed, including antibodies against cancer stem cells leading to early cancer detection by MRI means. The same nanoparticles will be used simultaneously as functional nanocarriers and heating inductors in order to provide a combined therapeutic modality. The synergistic effects of drugs, peptides, small RNAs and heat will be evaluated to determine the effectiveness of different therapeutic combinations. Interestingly, the use of ligands will favour the specific application of the therapeutic modalities to cancer (stem) cells, increasing the effectiveness and reducing side effects. Thus, MultiFun multimodal therapeutic approach is designed to efficiently remove cancer cells, including cancer stem cells, from the tumour site. The toxicity of functionalised magnetic nanoparticles will be assessed in vitro and in vivo to warrant a safe use and shed some light on the risks. The distribution and activity evaluation of functionalised nanoparticles will be performed in human breast and pancreatic cancer xenograft models. The use of novel magnetic nanoparticles for biomedical applications provides opportunities for new instrumentation: 1) detection and quantification of magnetic nanoparticles in blood, urine and tissues, and 2) magnetic heating induction for raising cell temperature.
Consortium · 17 organisations
ATOS SPAIN SA
ES · €810,390
FUNDACION SECTOR PUBLICO ESTATAL CENTRO NACIONAL INVESTIGACIONES ONCOLOGICAS CARLOS III
ES · €445,920
THE UNIVERSITY OF MANCHESTER
UK · €838,107
THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
IE · €1,059,807
INSTITUT NATIONAL DES SCIENCES APPLIQUEES DE TOULOUSE
FR · €518,020
FYZIKALNI USTAV AV CR V.V.I
CZ · €449,999
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS
ES · €1,213,573
PHARMA MAR SA
ES · €219,912
SOLUCIONES NANOTCNOLOGICAS SL
ES
UNIVERSITE PARIS XII VAL DE MARNE
FR · €321,050
PEPRIC NV
BE · €496,148
LIQUIDS RESEARCH LTD
UK · €402,823
FUNDACION IMDEA NANOCIENCIA
ES · €875,680
QUEEN MARY UNIVERSITY OF LONDON
UK · €274,496
UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK
IE · €298,972
KING'S COLLEGE LONDON
UK · €571,937
UNIVERSITATSKLINIKUM JENA
DE · €1,003,160
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.